Lipid Nanoparticles: Production, Characterization and Stability

What are lipid nanoparticles?  How are they structured?  How are they formed? What techniques are best to characterize them?  How great is their potential as drug delivery systems?  These questions and more are answered in this comprehensive and highly readable work on lipid nanoparticles. This work...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Shah, Rohan (Συγγραφέας), Eldridge, Daniel (Συγγραφέας), Palombo, Enzo (Συγγραφέας), Harding, Ian (Συγγραφέας)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2015.
Σειρά:SpringerBriefs in Pharmaceutical Science & Drug Development,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03943nam a22005295i 4500
001 978-3-319-10711-0
003 DE-He213
005 20150729060414.0
007 cr nn 008mamaa
008 140828s2015 gw | s |||| 0|eng d
020 |a 9783319107110  |9 978-3-319-10711-0 
024 7 |a 10.1007/978-3-319-10711-0  |2 doi 
040 |d GrThAP 
050 4 |a RS380 
050 4 |a RS190-210 
072 7 |a TDCW  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
082 0 4 |a 615.19  |2 23 
100 1 |a Shah, Rohan.  |e author. 
245 1 0 |a Lipid Nanoparticles: Production, Characterization and Stability  |h [electronic resource] /  |c by Rohan Shah, Daniel Eldridge, Enzo Palombo, Ian Harding. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
300 |a IX, 97 p. 30 illus., 18 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a SpringerBriefs in Pharmaceutical Science & Drug Development,  |x 1864-8118 
505 0 |a Introduction -- Composition and structure -- Production techniques -- Characterization -- Physicochemical stability. 
520 |a What are lipid nanoparticles?  How are they structured?  How are they formed? What techniques are best to characterize them?  How great is their potential as drug delivery systems?  These questions and more are answered in this comprehensive and highly readable work on lipid nanoparticles. This work sets out to provide the reader with a clear and understandable understanding of the current practices in formulation, characterization and drug delivery of lipid nanoparticles. A comprehensive description of the current understanding of synthesis, characterization, stability optimization and drug incorporation of solid lipid nanoparticles is provided. Nanoparticles have attracted great interest over the past few decades with almost exponential growth in their research and application. Their small particle size and subsequent high surface area make them ideal in many uses, but particularly as drug carrier systems. Nanoparticles made from lipids are especially attractive because of their enhanced biocompatibility imparted by the lipid. The work provides a detailed description of the types of lipid nanoparticles available (e.g. SLN, NLC, LDC, PLN) and how they range from imperfect crystalline to amorphous in structure. Current thoughts on where drugs are situated (e.g. in the core, or at the interface) and how this can be manipulated are discussed.  The many techniques for production, including the author’s own variant of microwave heating, are fully discussed. Techniques for measuring arguably the most important characteristics of particle size and polydispersity are discussed, along with techniques to measure crystallinity, shape and drug capacity.  Finally, a full chapter on techniques for measuring stability, both in the absence and presence of drugs, is discussed, along with suggestions on how to optimize that stability. This work appeals to students of colloid science, practitioners of research into drug delivery and academics alike. 
650 0 |a Medicine. 
650 0 |a Pharmaceutical technology. 
650 0 |a Biotechnology. 
650 0 |a Lipids. 
650 1 4 |a Biomedicine. 
650 2 4 |a Pharmaceutical Sciences/Technology. 
650 2 4 |a Biotechnology. 
650 2 4 |a Lipidology. 
700 1 |a Eldridge, Daniel.  |e author. 
700 1 |a Palombo, Enzo.  |e author. 
700 1 |a Harding, Ian.  |e author. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319107103 
830 0 |a SpringerBriefs in Pharmaceutical Science & Drug Development,  |x 1864-8118 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-10711-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)